Guanlin Li

The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells

Qiang Zhou, L. Kong, Junxia Zhang, 2014, OncoTargets and therapy.

LncRNA NR2F2‐AS1 promotes tumourigenesis through modulating BMI1 expression by targeting miR‐320b in non‐small cell lung cancer

Shijie Zhang, Huaqi Wang, Qianqian Sun, 2018, Journal of cellular and molecular medicine.

Local administration of a novel siRNA modality into the CNS extends survival and improves motor function in the SOD1G93A mouse model for ALS

R. Place, V. Huang, Zubao Gan, 2023, bioRxiv.